USANA Health Sciences Announces Third Quarter Financial Results *Net sales increased by 5.2% to $173.7 million *Previously announced strategies implemented in second and third quarter result in 4.2% decrease in net earnings; EPS decreased 1.7% to $1.16 *Company provides updated 2013 net sales and earnings growth outlook Business Wire SALT LAKE CITY -- October 22, 2013 USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 28, 2013. Financial Performance For the third quarter of 2013, net sales increased by 5.2% to $173.7 million, compared with $165.2 million in the prior-year period. The growth in net sales was driven by increases in both the Company’s Asia Pacific and North America/Europe regions. Net sales for the quarter were negatively impacted by: (i) an estimated $5.9 million due to the worldwide policy changes that the Company implemented at the end of the second quarter of this year, which require customers to purchase products in their home markets; (ii) $4.6 million due to the strategic price discounts that the Company announced at its International Convention in August and earlier this year; and (iii) $2.0 million due to changes in currency exchange rates. Net earnings for the third quarter decreased by 4.2% to $16.8 million, compared with the prior-year period. This decrease was due primarily to higher Associate Incentives expense, attributable to the enhancements that the Company made to its Associate Compensation Plan at its August 2013 International Convention. Additionally, the effective tax rate for the third quarter was 420 basis points, or $1.0 million, higher than the previous year, due primarily to one-time tax benefits recognized in the third quarter of 2012. Earnings per share for the quarter decreased by 1.7% to $1.16, compared with $1.18 in the third quarter of the prior year. This decrease in earnings per share was attributable to lower net earnings, partially offset by a lower number of diluted shares outstanding from the Company’s share repurchases during the 12 months ended September 29, 2013. Total diluted common shares outstanding as of September 28, 2013 were 14.4 million, compared with 14.9 million as of September 29, 2012. “During the third quarter, we implemented a number of strategic initiatives at our 2013 International Convention,” said Dave Wentz, the Company’s Chief Executive Officer. “These initiatives, which include price reductions and enhancements to our Associate compensation plan, are intended to drive long-term, sustainable customer growth for USANA. The combination of these initiatives and the worldwide policy changes that we introduced in the second quarter had the meaningful impact that we anticipated on our third-quarter results. Although it is still early, these initiatives have already produced several anticipated positive results, including: (i) an increase of approximately 30% in our worldwide Auto Order sales; (ii) an increase of approximately 40% in the number of weekly commission checks earned by Associates; and (iii) an increase of approximately 30% in the number of first-time check earners with USANA. Going forward, we expect these initiatives to contribute to the growth of our worldwide customer counts.” Regional Results Net sales in Asia Pacific increased by 4.6% to $107.4 million, compared with $102.7 million for the third quarter of the prior year. This improvement was due primarily to sales growth in the Southeast Asia Pacific region, which was driven by meaningful growth in Singapore and Malaysia. Sales in the Greater China region were flat, with significant growth in Mainland China and Taiwan, offset by a sales decrease in Hong Kong. Net sales in North America/Europe increased by 6.1% to $66.3 million, compared with $62.5 million in the prior-year period. This improvement was due primarily to sales growth in Mexico and Canada, as well as the addition of our newest market, Colombia, which generated $1.4 million in sales during its first quarter of operations. The sales growth in these markets reflected increases in both the number of Active Associates and Preferred Customers. “The performance of our North America region reflects the momentum we are generating in Mexico, Canada and, most recently, Colombia,” continued Wentz. “Our results in Greater China were in line with our expectations, considering the worldwide policy changes that we implemented during the second quarter of this year. Our expectations for Greater China have not changed and our team continues to focus on growth in Mainland China. I am confident in the strength of our underlying business in all of our regions and believe that we have implemented the right strategies to drive long-term growth.” The Company continued to generate significant cash from operations and ended the quarter with $115.3 million in cash and cash equivalents. For the third quarter, cash generated from operations totaled $17.3 million. During the quarter, the Company did not repurchase any shares of its common stock and ended the quarter with $13.6 million remaining under the board authorized repurchase program. Outlook The Company provided the following updated consolidated net sales and earnings per share outlook for 2013: *Consolidated net sales between $705 million and $710 million, versus the previous outlook of between $700 and $720 million *Earnings per share between $5.35 and $5.40, versus the previous outlook of between $5.30 and $5.45 Chief Financial Officer, Paul Jones, commented, “We are tightening our guidance range as we head into the final quarter of 2013 and expect USANA to once again deliver record results in 2013. Although we expect continued pressure on our operating results for the next few quarters, we are confident that we will deliver growth during this period. More importantly, we believe that the strategies that we have implemented will increase our long-term growth potential.” Conference Call USANA will hold a conference call and webcast to discuss this announcement with investors on Wednesday, October 23, 2013 at 11:00 AM Eastern Time. Investors may listen to the call by accessing USANA’s website at http://www.usanahealthsciences.com. About USANA USANA develops and manufactures high-quality nutritional, personal care, and weight-management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium and Colombia. More information on USANA can be found at http://www.usanahealthsciences.com. Safe Harbor This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. USANA Health Sciences, Inc. Consolidated Statements of Earnings (In thousands, except per share data) (Unaudited) Quarter Ended Nine Months Ended 29-Sep-12 28-Sep-13 29-Sep-12 28-Sep-13 Net sales $ 165,175 $ 173,691 $ 480,196 $ 531,909 Cost of sales 30,343 31,491 85,633 93,657 Gross profit 134,832 142,200 394,563 438,252 Operating expenses Associate 70,406 76,361 209,316 224,017 incentives Selling, general and 40,342 41,145 115,150 126,527 administrative Earnings from 24,084 24,694 70,097 87,708 operations Other income 267 76 177 (33 ) (expense) Earnings before 24,351 24,770 70,274 87,675 income taxes Income taxes 6,861 8,017 22,288 28,933 NET EARNINGS $ 17,490 $ 16,753 $ 47,986 $ 58,742 Earnings per $ 1.18 $ 1.16 $ 3.19 $ 4.16 share - diluted Weighted average shares 14,884 14,393 15,064 14,132 outstanding - diluted USANA Health Sciences, Inc. Consolidated Balance Sheets (In thousands) (Unaudited) As of As of ASSETS 29-Dec-12 28-Sep-13 Current Assets Cash and cash equivalents $ 70,839 $ 115,349 Inventories 36,481 45,671 Other current assets 25,225 35,105 Total current assets 132,545 196,125 Property and equipment, net 61,751 60,432 Goodwill 17,890 18,105 Intangible assets, net 42,085 42,078 Deferred income taxes 5,956 3,562 Other assets 7,128 11,031 Total assets $ 267,355 $ 331,333 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable $ 7,040 $ 8,061 Other current liabilities 63,804 74,474 Total current liabilities 70,844 82,535 Other long-term liabilities 938 1,127 Deferred income taxes 10,001 9,022 Stockholders' equity 185,572 238,649 Total liabilities and stockholders' equity $ 267,355 $ 331,333 USANA Health Sciences, Inc. Sales by Region (Unaudited) (In thousands) Quarter Ended 29-Sep-12 28-Sep-13 Region North America $ 62,490 37.8 % $ 66,294 38.2 % / Europe Asia Pacific Southeast Asia 35,709 21.6 % 40,230 23.1 % Pacific Greater China 59,722 36.2 % 59,768 34.4 % North Asia 7,254 4.4 % 7,399 4.3 % Asia Pacific 102,685 62.2 % 107,397 61.8 % Total Total $ 165,175 100.0 % $ 173,691 100.0 % Active Associates by Region ^(1) (Unaudited) As of 29-Sep-12 28-Sep-13 Region North America / 79,000 32.6 % 82,000 33.5 % Europe Asia Pacific Southeast Asia 58,000 24.0 % 60,000 24.5 % Pacific Greater 97,000 40.1 % 94,000 38.3 % China North Asia 8,000 3.3 % 9,000 3.7 % Asia Pacific 163,000 67.4 % 163,000 66.5 % Total Total 242,000 100.0 % 245,000 100.0 % (1) Associates are independent distributors of our products who also purchase our products for their personal use. We only count as active those Associates who have purchased from us any time during the most recent three-month period, either for personal use or for resale. Active Preferred Customers by Region ^(2) (Unaudited) As of 29-Sep-12 28-Sep-13 Region North America / 52,000 81.3 % 58,000 81.7 % Europe Asia Pacific Southeast 6,000 9.4 % 8,000 11.3 % Asia Pacific Greater 5,000 7.8 % 3,000 4.2 % China North Asia 1,000 1.6 % 2,000 2.8 % Asia Pacific 12,000 18.8 % 13,000 18.3 % Total Total 64,000 100.0 % 71,000 100.0 % (2) Preferred Customers purchase our products strictly for their personal use and are not permitted to resell or to distribute the products. We only count as active those Preferred Customers who have purchased from us any time during the most recent three-month period. Contact: USANA Health Sciences, Inc. Investors contact: Patrique Richards, 801-954-7961 Investor Relations email@example.com Media contact: Dan Macuga, 801-954-7280 Public Relations
USANA Health Sciences Announces Third Quarter Financial Results
Press spacebar to pause and continue. Press esc to stop.